首页> 外国专利> A freeze-dried cholera attenuated strain for oral vaccination with improved biological safety

A freeze-dried cholera attenuated strain for oral vaccination with improved biological safety

机译:用于口服疫苗的冻干霍乱减毒株,具有更高的生物安全性

摘要

The present invention discloses new live attenuated strains for oral immunization against cholera that are provided in freeze dried formulations for long term storage and administration to humans. These strains combine the two most important properties of live attenuated cholera vaccine candidates. One such property is being well tolerated by people ingesting them. This was achieved by virtue of mutations already described in the art. The second property is having enhanced environmental safety due to the absence of VGJ¦ DNA in their genomes and also due to null mutations in the mshA gene or other spontaneous mutations conducive to the lack of MSHA type IV fimbria on the bacterial surface. This was done envisioning that VGJ¦ is a filamentous phage able to recombine with CTX¦ and disseminate the cholera toxin genes. This VGJ¦ phage as well as the VGJ¦-CTX¦ recombinants uses the MSHA fibers as receptor. Being devoid of MSHA fimbria the vaccine candidates are protected from acquiring CTX¦ from the recombinant hybrid VGJ¦-CTX¦. Being devoid of VGJ¦, the vaccine candidates are impaired in the dissemination of CTX¦, via VGJ¦.
机译:本发明公开了用于口服抗霍乱的新的减毒活菌株,其以冷冻干燥的制剂形式提供,用于长期储存和对人给药。这些菌株结合了减毒活霍乱疫苗候选者的两个最重要的特性。人们摄取它们时很好地容忍了这样一种属性。这通过本领域已经描述的突变来实现。第二个特性是由于其基因组中不存在VGJβDNA以及由于mshA基因中的无效突变或其他自发突变导致细菌表面缺乏MSHA IV型菌毛而具有增强的环境安全性。设想VGJβ是能够与CTXβ重组并传播霍乱毒素基因的丝状噬菌体。该VGJβ噬菌体以及VGJβ-CTXβ重组体均使用MSHA纤维作为受体。由于没有MSHA菌毛,因此可以保护候选疫苗免于从重组杂种VGJβ-CTXβ获得CTXβ。由于缺乏VGJβ,因此候选疫苗通过VGJβ在CTXβ的传播中受到损害。

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号